Veritas Aortic Solutions, a medical device company based in Costa Mesa, has successfully secured $12 million in seed funding. The investment, which includes contributions from Cedars-Sinai Intellectual Property Company among other investors, is aimed at advancing the development of a non-surgical device designed to treat high-risk root and ascending aortic diseases. The company’s co-founder and CEO, J. Brent Ratz, expressed gratitude for the support from experienced MedTech investors and esteemed healthcare organizations, highlighting the potential to accelerate the technology’s progression towards its initial clinical application.
Did Veritas Aortic Solutions secure $12M in seed funding?
